CN / EN
联系我们
KYKJT
Reltecimod

Reltecimod

  • 80%,90%,95%,98%,99%
  • 询价

Reltecimod (AB-103) 是一种 T 细胞特异性表面糖蛋白 CD28 (TP44) 拮抗剂。Reltecimod对不同的细菌感染、细菌外毒素和内毒素以及电离辐射都有良好的抗性作用。Reltecimod 通过靶向和减弱关键的 CD28/B7-2 共刺激通路来调节炎症反应,而不抑制它。Reltecimod 可用于研究坏死性软组织感染 (NSTIs)。

产品信息

产品名称Reltecimod
产品描述Reltecimod (AB-103) is an antagonist of the T cell-specific surface glycoprotein CD28 (TP44). Reltecimod has good resistance effects against different bacterial infections, bacterial exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates inflammatory responses by targeting and attenuating, but not inhibiting, the critical CD28/B7-2 costimulatory pathway. Reltecimod can be used in research on necrotizing soft tissue infections (NSTIs).
生物活性Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs).
分子式C46H72N10O15S
CAS号1447799-33-8
性状Solid
颜色White to off-white
序列{d-Ala}-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-{d-Ala}
序列缩写{d-Ala}-SPMLVAYD-{d-Ala}
储存方式Sealed storage, away from moisture
上一个:
Daptomycin
下一个:
LL-37, human
置顶